Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the June 16, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports detailed vote tallies for four proposals: election of 7 directors, ratification of Grant Thornton LLP as auditor, Say-On-Pay advisory vote, and approval of the amended Omnibus Incentive Plan. All proposals passed with strong majorities, making this a material disclosure of shareholder actions that affects the composition of the board and governance structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Autodesk held its 2026 Annual Meeting of stockholders, at which eleven directors were elected to the Board and stockholders voted on four proposals: ratification of the independent auditor, an advisory vote on executive compensation, approval of a certificate amendment relating to officer exculpation, and a proposal regarding stockholder special meeting rights. The detailed vote results for each director and proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Match Group held its annual stockholder meeting on June 16, 2026, with voting results on four matters: election of four directors, a Say on Pay proposal (which failed to receive majority approval), approval of the Second Amended and Restated 2024 Stock and Annual Incentive Plan, and ratification of Ernst & Young LLP as auditor. The failed Say on Pay vote signals material stockholder dissatisfaction with executive compensation practices.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-18
EX-99.1
The exhibit is a press release announcing the results of OceanPal's 2026 Annual General Meeting of Shareholders held on June 16, 2026. It discloses approval of three proposals: election of two Class II Directors, approval of a name change from "OceanPal Inc." to "SVRN, Inc.", and appointment of CBIZ CPAs P.C. as independent auditors. This is a direct disclosure of shareholder vote results, which is material to investors as it confirms governance actions and a significant corporate name change.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting held on June 17, 2026. The filing reports voting outcomes for three matters: election of eight directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three matters passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors as it confirms governance actions taken at the annual meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Pegasystems' 2026 Annual Meeting of Shareholders held on June 16, 2026. The filing presents voting results for three proposals: (1) reelection of eight directors, (2) non-binding advisory vote on executive compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of SLM Corporation's Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for three proposals: election of 13 directors, advisory vote on executive compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each director and proposal are the core content, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the June 17, 2026 Annual Meeting of Stockholders, covering four proposals: election of five directors, approval of an amendment to the 2023 Stock Incentive Plan, ratification of RSM US LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed vote tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures and is material to investors assessing corporate governance and management accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from eBay's 2026 Annual Meeting of Stockholders held on June 17, 2026, covering four proposals: election of 11 directors, ratification of auditors, advisory vote on executive compensation, and a stockholder proposal on special meeting thresholds. The filing presents detailed voting tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Cognition Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports final vote tallies for two proposals: election of Class II directors (Aaron Fletcher, Ph.D. and Lisa Ricciardi) and ratification of Ernst & Young LLP as independent auditors. The detailed voting counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm governance outcomes and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Bicycle Therapeutics' annual general meeting held on June 17, 2026. The filing reports the outcomes of nine proposals including director re-elections (Felix Baker, Hervé Hoppenot), advisory approval of named executive officer compensation, auditor ratification and re-appointment, and approval of remuneration policies. All proposals passed with substantial majorities, as required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-18
Item 5.07
Shareholders approved three proposals at a special meeting: an Extension Amendment to extend the Business Combination deadline from June 24, 2026 to June 24, 2027 (with up to twelve one-month extensions), a Trust Agreement Amendment, and an Adjournment Proposal. All three proposals passed with substantially identical vote tallies (16,621,609 for, 809,296 against, 0 abstentions), and 2,598,697 Class A shares were redeemed for approximately $27.8 million in connection with the Extension Amendment vote.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-18
The 6-K discloses results of Grifols' Ordinary General Shareholders' Meeting held on June 18, 2026. The filing reports that shareholders approved most proposals, including dividend distributions (EUR 56.1 million ordinary dividend plus EUR 0.01 per Class B share preferred dividend), re-election of directors, auditor re-election, and capital authorization resolutions. One proposal (Item Eleventh regarding authorization to call extraordinary meetings with 15 days' notice) failed to reach sufficient majority. The disclosure of shareholder voting outcomes on material matters such as dividends, director elections, and capital authorizations is a core shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Bank First Corp held its 2026 Annual Meeting of Shareholders on June 15, 2026, with shareholders voting on four proposals: election of three directors (Eldred, McFarlane, and Sprang), ratification of Forvis Mazars as independent auditor, an advisory vote on named executive officer compensation, and approval of an amendment to the Articles of Incorporation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of FS KKR Capital Corp's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for director elections (Proposal No. 1), the Share Issuance Proposal (Proposal No. 2, adjourned to August 20, 2026), and the 1940 Act Section 61(a)(4) Issuance Proposal (Proposal No. 3, approved). The filing provides detailed vote tallies for each director nominee and the warrant/options issuance proposal, which are material governance and capital authorization matters affecting shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
MultiSensor AI Holdings held its Annual Meeting on June 12, 2026, with shareholders voting on three proposals: election of five directors (Margaret Chu, Stuart Flavin III, Daniel Friedberg, David Gow, and Petros Kitsos), ratification of Weaver and Tidwell L.L.P. as independent auditor, and approval of an amendment to the 2023 Incentive Award Plan increasing authorized shares by 500,000 to 661,012 total shares. All three proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This 8-K Item 5.07 discloses the results of Structure Therapeutics' 2026 Annual General Meeting of Shareholders held on June 17, 2026, including voting outcomes for three proposals: election of three Class III directors (Ted W. Love, M.D., Raymond Stevens, Ph.D., and Daniel G. Welch), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure of shareholder vote results at an annual meeting is a material event affecting investor understanding of corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Ironwood Pharmaceuticals held its Annual Meeting of Stockholders and disclosed voting results on multiple matters, including election of eight directors, advisory approval of named executive officer compensation, approval of a Plan Amendment increasing equity incentive plan shares by 10 million, and ratification of KPMG LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 17, 2026, covering four proposals: election of six directors, ratification of Grant Thornton LLP as auditor, Say-on-Pay advisory vote, and approval of the Sixth Amended and Restated 2010 Equity Incentive Plan. The filing presents detailed vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Tidewater held its Annual Meeting of Stockholders on June 16, 2026, with 89.57% attendance. Stockholders approved all four proposals: election of seven directors, advisory vote on executive compensation, amendment to the 2021 Stock Incentive Plan increasing available shares by 2,250,000, and ratification of PricewaterhouseCoopers LLP as auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the complete voting results from BJ's Wholesale Club's annual meeting of shareholders held on June 18, 2026, covering seven distinct proposals: election of ten directors, advisory vote on named executive officer compensation, frequency of future compensation votes, ratification of PricewaterhouseCoopers LLP as independent auditor, and shareholder proposals on majority voting and environmental reporting. The filing explicitly states voting tallies (FOR, AGAINST, WITHHELD, ABSTAINED, BROKER NON-VOTES) for each proposal, which is the core content of a shareholder_vote_results disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on June 16, 2026, covering five proposals: director elections (Proposal 1), auditor ratification (Proposal 2), equity plan amendment (Proposal 3), executive compensation advisory vote (Proposal 4), and meeting adjournment (Proposal 5). The filing presents voting tallies for each proposal, which is the core content of Item 5.07 disclosures. Director elections and equity plan amendments are material to investors' assessment of governance and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Protagonist Therapeutics held an Annual Meeting of Stockholders at which shareholders voted on four proposals: election of two Class I directors (Dinesh V. Patel and Lewis T. Williams), an advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as the independent auditor, and approval of the 2026 Equity Incentive Plan. Final voting results for all four proposals are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Willdan Group held its Annual Meeting of Stockholders on June 17, 2026, with detailed voting results disclosed for all four proposals: director elections, auditor ratification, advisory compensation vote, and amendments to the 2008 Performance Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of Elauwit Connection's annual meeting of stockholders held on June 18, 2026, including voting outcomes for three proposals: election of three directors (Leslie Goodman, David O'Brien, and Barry Rubens), ratification of WithumSmith+Brown, PC as independent auditor, and approval of an adjournment proposal. The detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and broker non-votes) are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Zura Bio held its Annual Meeting of Shareholders on June 17, 2026, with voting results on four proposals: election of eight directors, ratification of WithumSmith+Brown, PC as independent auditor, approval of the Amended 2023 Equity Incentive Plan, and an adjournment proposal. Detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the final voting results from AlTi Global's June 17, 2026 Annual Meeting of Stockholders, including tabulated votes for the election of seven directors and ratification of KPMG LLP as independent auditor. The detailed vote counts (For, Withhold/Against, Broker Non-Votes) for each proposal are the core content, matching the shareholder_vote_results event type precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of PENN Entertainment's 2026 Annual Meeting of Shareholders held on June 16, 2026. The filing presents voting results for five matters: election of Class III directors (Marla Kaplowitz, Jane Scaccetti, Fabio Schiavolin, and Jay Snowden), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, approval of the third amendment to the 2022 Long-Term Incentive Compensation Plan, and an advisory vote on annual director elections. All results are presented with vote counts for, against, abstentions, and broker non-votes, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-18
EX-99.1
This press release discloses the results of Satellos' Annual Meeting of Shareholders held June 17, 2026, including voting results for the election of nine directors and re-appointment of PricewaterhouseCoopers LLP as auditors. The exhibit explicitly presents a detailed voting table showing votes for and against each director nominee, with all nominees elected. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, material to investors as it confirms board composition and auditor retention.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Green Thumb Industries held its 2026 Annual Meeting of Shareholders, with voting results disclosed on five proposals: board size, election of seven directors, advisory say-on-pay compensation approval, appointment of Baker Tilly US, LLP as auditor, and amendment to Super Voting Share conversion provisions (lowering the automatic conversion trigger from 50% to 25% of original holdings).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-18
EX-99.1
This press release discloses the results of an Extraordinary General Meeting of Shareholders held on June 17, 2026. Shareholders voted in favor of all resolutions, including approval of share cancellation from a buyback program and amendments to the articles of association regarding board indemnification and shareholder meeting procedures. The disclosure of shareholder vote results is a material governance event that affects the registrant's capital structure and governance framework.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an annual meeting of stockholders held on June 16, 2026. The filing presents voting results for four proposals: election of directors (Proposal 1), ratification of auditor MaloneBailey, LLP (Proposal 2), approval of warrant issuance exceeding 19.99% of outstanding shares under Nasdaq Rule 5635(d) (Proposal 3), and approval of a reverse stock split amendment (Proposal 4). The disclosure is material because the warrant approval and reverse stock split authorization represent significant corporate actions affecting shareholder equity and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from Blue Ridge Bankshares' June 17, 2026 Annual Meeting of Shareholders. The filing reports voting outcomes for two proposals: (1) election of five directors (Heather M. Cozart, Harry Golliday, Otis S. Jones, Anthony R. Scavuzzo, and William W. Stokes), and (2) ratification of Elliott Davis, PLLC as independent auditor. All directors were elected with substantial majorities, and the auditor ratification passed overwhelmingly. This is a material disclosure as it documents the composition of the board and auditor approval, both of which affect investor assessment of governance and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of T-Mobile's Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for three proposals: election of 13 directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Ouster held its 2026 Annual Meeting of Stockholders on June 17, 2026, with shareholders voting on five proposals: election of two Class II directors (Phillip M. Eyler and Angus Pacala), ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on named executive officer compensation, amendment to increase authorized common shares from 100 million to 200 million, and amendment regarding officer exculpation. Four of the five proposals passed, with the officer exculpation amendment failing.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of Mirum Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 15, 2026, including voting outcomes for three proposals: election of three Class I directors (Lon Cardon, William Fairey, and Timothy Walbert), ratification of Ernst & Young LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies for each proposal are the core disclosure, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of OPKO Health's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing presents voting results for four proposals: election of eleven directors, approval of the 2026 Equity Incentive Plan, advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of Guardant Health's annual stockholder meeting held on June 17, 2026, including voting outcomes on four proposals: director elections (Proposal 1), auditor ratification (Proposal 2), say-on-pay advisory vote (Proposal 3), and frequency of future say-on-pay votes (Proposal 4). The filing presents detailed vote tallies for each proposal, which is the core disclosure required under Item 5.07. Notably, Proposal 3 (compensation advisory vote) was not approved, which is material information for investors assessing executive compensation governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of Block, Inc.'s 2026 annual meeting of stockholders held on June 16, 2026, including voting outcomes on four proposals: election of four Class II directors (all elected), advisory approval of named executive officer compensation (approved), ratification of Ernst & Young LLP as independent auditor (approved), and a stockholder proposal to establish a board-level technology committee (not approved). The detailed vote tallies and quorum information are characteristic of shareholder vote results disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from Corsair Gaming's 2026 Annual Meeting held on June 16, 2026. The filing reports voting outcomes for two proposals: (1) election of Class III director nominees Thi L. La and Randall J. Weisenburger, and (2) ratification of KPMG LLP as independent auditor. Both proposals passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Agios Pharmaceuticals held its Annual Meeting of Stockholders, at which stockholders elected Class I directors (Rahul Ballal, Brian Goff, Cynthia Smith), approved an advisory vote on named executive officer compensation, approved an amendment to the 2023 Stock Incentive Plan increasing the share reserve by 2,000,000 shares, and ratified PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Xometry's 2026 Annual Meeting held on June 16, 2026, filed under Item 5.07. The filing reports final voting tallies for three proposals: election of three Class II directors (Roy Azevedo, Fabio Rosati, and Katharine Weymouth), advisory approval of named executive officer compensation, and ratification of Deloitte and Touche LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Stockholders voted at the June 16, 2026 Annual Meeting on four proposals: election of Class I directors (Herring, Kidd, Rudow), ratification of RSM US LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the 2026 Equity Incentive Plan. All proposals received shareholder approval with tabulated voting results disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Standard Biotools held its Annual Meeting of Stockholders on April 24, 2026, with stockholders voting on five proposals: election of three Class I directors (Michael Egholm, Thomas Carey, and Eli Casdin), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2017 Employee Stock Purchase Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from PJT Partners' 2026 Annual Meeting held on June 18, 2026. The filing presents final vote tallies for three proposals: director elections (K. Don Cornwell, Peter L.S. Currie, Thomas M. Ryan), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that investors rely upon to confirm board composition and audit firm appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from SAB Biotherapeutics' 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing reports the outcomes of two proposals: (1) election of four Class II directors (David Zaccardelli, David Link, Katie Ellias, and Andrew Moin) with detailed vote tallies, and (2) ratification of EisnerAmper LLP as independent auditor. The disclosure includes quorum information (76.12% attendance) and complete voting results for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from a special meeting held on June 18, 2026. The filing reports the final voting tallies on Proposal 1 authorizing the Company to issue common stock below net asset value (NAV), with detailed vote counts for and against. This authorization to issue dilutive equity is material to investors as it affects potential share dilution and the Company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Contango held its 2026 Annual Meeting of Stockholders on June 18, 2026, at which all seven director nominees were elected, Baker Tilly US, LLP was ratified as auditor, and non-binding advisory votes on executive compensation and say-on-pay frequency (annual) were approved.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from IonQ's 2026 Annual Meeting of Stockholders held on June 16, 2026, covering three proposals: election of Class II directors (Kathryn K. Chou and William F. Scannell), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
RYTHM held its 2026 Annual Meeting of Stockholders on June 16, 2026, with voting results on three proposals: election of seven directors, ratification of GuzmanGray as independent auditor, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan increasing available shares by 115,000.
View raw filing on EDGAR →